National Research (NASDAQ:NRC) Stock Passes Above Two Hundred Day Moving Average – Should You Sell?

National Research Corporation (NASDAQ:NRC) passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $18.53 and traded as high as $21.69. National Research shares last traded at $20.94, with a volume of 96,935 shares traded.

Analysts Set New Price Targets

Several analysts recently weighed in on NRC shares. Citizens Jmp lifted their price objective on shares of National Research from $23.00 to $26.00 and gave the company a “market outperform” rating in a research report on Wednesday, July 29th. Wall Street Zen lowered shares of National Research from a “buy” rating to a “hold” rating in a research note on Saturday, August 15th. Finally, Weiss Ratings raised National Research from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Friday, August 21st. One equities research analyst has rated the stock with a Buy rating and one has issued a Hold rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $26.00.

National Research Trading Down 1.3%

The company has a current ratio of 0.65, a quick ratio of 0.65 and a debt-to-equity ratio of 13.13. The firm has a market cap of $458.90 million, a PE ratio of 80.60 and a beta of 0.34. The company’s 50-day moving average is $21.27 and its 200 day moving average is $18.58.

National Research (NASDAQ:NRC) last issued its quarterly earnings data on Tuesday, July 28th. The company reported $0.31 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.15) by $0.46. National Research had a return on equity of 164.26% and a net margin of 4.18%.The company had revenue of $35.39 million during the quarter, compared to analysts’ expectations of $34.90 million.

National Research Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 9th. Stockholders of record on Friday, September 25th will be issued a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a dividend yield of 3.2%. The ex-dividend date is Friday, September 25th. National Research’s payout ratio is 256.00%.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of NRC. M&T Bank Corp boosted its stake in National Research by 6.4% in the 2nd quarter. M&T Bank Corp now owns 13,608 shares of the company’s stock worth $229,000 after purchasing an additional 823 shares during the period. Sei Investments Co. raised its stake in shares of National Research by 1.2% in the 3rd quarter. Sei Investments Co. now owns 76,270 shares of the company’s stock valued at $975,000 after purchasing an additional 900 shares during the period. Russell Investments Group Ltd. lifted its holdings in shares of National Research by 85.6% in the third quarter. Russell Investments Group Ltd. now owns 1,997 shares of the company’s stock valued at $26,000 after purchasing an additional 921 shares in the last quarter. Invesco Ltd. lifted its holdings in shares of National Research by 6.3% in the second quarter. Invesco Ltd. now owns 17,368 shares of the company’s stock valued at $292,000 after purchasing an additional 1,022 shares in the last quarter. Finally, Alliancebernstein L.P. boosted its position in shares of National Research by 6.3% during the third quarter. Alliancebernstein L.P. now owns 18,499 shares of the company’s stock worth $236,000 after buying an additional 1,100 shares during the period. Institutional investors own 47.26% of the company’s stock.

About National Research

National Research Corp (NASDAQ: NRC), also known as NRC Health, is a healthcare analytics and performance improvement company specializing in patient and employee experience measurement. The company’s cloud-based platform enables healthcare providers to collect real-time feedback through patient satisfaction surveys, post-discharge outreach, and employee engagement tools. NRC Health integrates clinical, operational and financial data to deliver actionable insights that support quality improvement initiatives and value-based care programs.

Since its founding in the early 1990s and headquartered in Lincoln, Nebraska, National Research has expanded beyond its regional roots to serve more than 1,600 hospitals and 12,000 care sites across the United States and Canada.